Leadership Instincts: Survival Skills in a Complex World  |  Technology Inceptions: LG Ultragear Gaming Speaker GP9  |  Teacher Insights: Focus, Gaming Mode in Zoom Meet  |  Management lessons: Work Ethics for a Post Pandemic World  |  Career News: 13 Japanese companies to attend JAPAN DAY 2021 @IIT Hyderabad  |  Higher Studies: IELTS Mock Tests: Benefits and Characteristics  |  Teacher Insights: New Features in Moodle 4.0  |  Policy Indications: India-US Launch Climate Action and Finance Mobilisation Dialogue  |  Science Innovations: Stanford University Develops Algorithm to Predict Molecular Structures  |  Technology Inceptions: Oxygen Concentrator, Generation System Developed by Indian Institute of Science  |  Teacher Insights: Early Intervention in Children Good to Prevent Dyslexia  |  Parent Interventions: Cognitive Stimulation Lowers Dementia Risk  |  Parent Interventions: Elderly Cope Better with Pandemic  |  Policy Indications: Use of Copyrighted Works in Online Education  |  Parent Interventions: Maternal Voice Reduces Pain in Preemies  |  
June 02, 2021 Wednesday 11:47:52 AM IST

DST supported SAIF facility at Panjab University partners with Molekule, USA

COVID wards and ICUs at several hospitals in Chandigarh, Punjab, Uttarakhand, and Himachal Pradesh will soon be able to improve their ventilation facilities with the help of air purification units from a US-based company through an effort by Panjab University.  Department of Science and Technology supported Sophisticated Analytical Instrumentation Facility, Panjab University Chandigarh (SAIF, PUC) has collaborated with Molekule, a USA based air purifying manufacturer, to assemble and optimise Molekule’s air purifiers in about 10 hospitals so far this activity is still going on the number is likely to change with progress of this work. The partnership has led to donation of air purifiers Molekule & Air Pro RX units to hospitals across the country. Nearly 6 states have been covered till date, with efforts going on to cover most of the Covid affected states of India to help aid in the battle against the virus and provide patients, doctors, and staff with much-needed clean air. Installation of the air purifier will help prevent transmission of COVID 19 through exposure to aerosolized respiratory droplets by facilitating adequate indoor air purification and ventilation in the hospitals. It can help address concerns to the health of citizens and healthcare workers arising on account of the COVID-19 pandemic.

Molekule's core technology, Photoelectrochemical oxidation (PECO), is designed to destroy airborne pollutants like viruses, bacteria, mold, or chemicals in the air known as Volatile organic compounds (VOCs). Tests on PECO for these Molekule Air purifiers indicate upto 99.99% inactivation of coronavirus strains (porcine & bovine) and H1N1 flu virus, upto 95% destruction of VOCs and ozone (airborne chemicals), and upto 99.9% destruction of bacteria, mold, and viruses in the air.

In the first batch, Molekule Air Purifier Mini & Molekule Air Pro RX units were received, assembled, and tested at SAIF, PUC, by its technical staff members. Molekule Air Pro RX units had been originally designed for medical purposes in the United States and optimized for air purification in multipurpose facilities in hospitals to cater for huge areas such as emergency wards, ICUs, and so on and can now play a significant role in containing the rapid spread of COVID 19 in India.